Future Prospects of Global Laboratory Proficiency Testing Market

Image
Laboratory Proficiency Testing Market  The global Laboratory Proficiency Testing Market is estimated to be valued at US$ 1.29 billion in 2023 and is expected to exhibit a CAGR of 7.3% over the forecast period 2023 - 2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: Laboratory proficiency testing involves evaluating the performance of laboratories for a given scope of testing through inter-laboratory comparisons. It helps assess the quality and competence of laboratories by determining reproducibility and accuracy of test results. Proficiency testing products are used by laboratories to determine method validity and accuracy, and improve testing processes. Market Key Trends: One of the major trends in the laboratory proficiency testing market is the growing number of accredited medical laboratories. Accreditation assures compliance with ISO 15189 and ISO/IEC 17025 standards, which require participation in proficiency testing programs. Acc...

Tuberculosis Drugs Market Overview, Market Restraints and Drive growth in R&D Investment

Tuberculosis Drugs Market
Tuberculosis Drugs Market 

Tuberculosis is a chronic disease that has spread over the world. Drug companies are concentrating their efforts on creating medications that can reduce the length of treatment and help overcome the hurdles of drug-susceptible and drug-resistant TB. There are two forms of TB treatment: first-line treatment, second-line treatment, and drug-resistant treatment.

Although advanced technologies and the development of novel therapies are expected to reduce the time it takes to treat tuberculosis, most cases can take up to 6 months to treat with currently available drugs. Despite existing medicines and ongoing TB treatment drug advances, patients' access to suitable TB medicines continues to be a challenge, particularly in the areas of multidrug-resistant TB and paediatric TB.

 

Increasing R&D Investments and New Drug Developments Are Expected to Drive Growth of the Tuberculosis Drugs Market

The tuberculosis drugs market is growing as a result of an increasing number of drug innovations. The TB Alliance, a nonprofit group based in the United States, has produced a novel medicine for treating tuberculosis that is very treatment-resistant. For example, TB Alliance got FDA clearance in August 2019 for Pretomnid, a bedaquiline and linezolid combination regimen designed and intended for the treatment of individuals with XDR-TB, or intolerant non-responsive MDR-TB.

Furthermore, in order to commercialise their newly produced pharmaceuticals, industry companies are focused on strategic collaborations. In April 2019, for example, Mylan, a pharmaceutical company, teamed up with the TB Alliance to commercialise the Pretomanid medication for the treatment of pulmonary tuberculosis (TB).

 

Tuberculosis Drugs Market – Restraints

The rising number of medicine recalls is a key stumbling block to the market's expansion. Manufacturers of tuberculosis drugs face obstacles such as an increase in product recalls due to packaging or manufacturing defects. In India, for example, Sandoz recalled a batch of tuberculosis (TB) medications due to improper packaging. Furthermore, the Philippines Food and Medicine Administration recalled Novartis' drug Onecure in 2016 due to an insufficient amount of rifampicin in the drug.

Furthermore, the growing prevalence of tuberculosis (TB) around the world is propelling the Tuberculosis Drugs market forward. According to the World Health Organization's Global Tuberculosis Report 2018, over 10 million persons worldwide were infected with tuberculosis in 2017.

Comments

Popular posts from this blog

Future Prospects of Global Laboratory Proficiency Testing Market

Survival Suits Market Size, Share, Outlook, and Opportunity Analysis, 2023-2030

Global Ophthalmoscopes Market Overview and Impact of Coronavirus (Covid-19) Pandemic